Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Podzamczer

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
HIV Medicine|August 2, 2016
Elvitegravir concentrations in seminal plasma in HIV-1-infected menA Imaz, J Niubó, A D Kashuba, et al.
AIDS (London, England)|June 21, 2001
Treatment of tuberculosis in HIV-infected patients: safety and antiretroviral efficacy of the concomitant use of ritonavir and rifampinS Moreno, D Podzamczer, R Blázquez, et al.
Epidemiology and Infection|June 11, 2004
Incidence and molecular typing of Mycobacterium kansasii in a defined geographical area in Catalonia, SpainM Santin, F Alcaide, M A Benitez, et al.
The Journal of Infection|November 1, 1990
Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDSC Montalban, J L Calleja, A Erice, et al.
Annals of Internal Medicine|August 1, 1995
Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study GroupD Podzamczer, J M Miró, F Bolao, et al.
AIDS (London, England)|October 1, 1993
A prospective study of the risk of tuberculosis among HIV-infected patientsA Guelar, J M Gatell, J Verdejo, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1997
pp65 antigenemia as a marker of future CMV disease and mortality in HIV-infected patientsD Podzamczer, E Ferrer, A García, et al.
HIV Clinical Trials|October 24, 2001
Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapyM Núñez, P Saballs, M E Valencia, et al.
Journal of Neurovirology|December 28, 2017
CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON studyT J Barber, A Imaz, M Boffito, et al.
Journal of Neurovirology|January 11, 2018
Correction to: CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON studyT J Barber, A Imaz, M Boffito, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
HIV Medicine|August 2, 2016
Elvitegravir concentrations in seminal plasma in HIV-1-infected menA Imaz, J Niubó, A D Kashuba, et al.
AIDS (London, England)|June 21, 2001
Treatment of tuberculosis in HIV-infected patients: safety and antiretroviral efficacy of the concomitant use of ritonavir and rifampinS Moreno, D Podzamczer, R Blázquez, et al.
Epidemiology and Infection|June 11, 2004
Incidence and molecular typing of Mycobacterium kansasii in a defined geographical area in Catalonia, SpainM Santin, F Alcaide, M A Benitez, et al.
The Journal of Infection|November 1, 1990
Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDSC Montalban, J L Calleja, A Erice, et al.
Annals of Internal Medicine|August 1, 1995
Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study GroupD Podzamczer, J M Miró, F Bolao, et al.
AIDS (London, England)|October 1, 1993
A prospective study of the risk of tuberculosis among HIV-infected patientsA Guelar, J M Gatell, J Verdejo, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1997
pp65 antigenemia as a marker of future CMV disease and mortality in HIV-infected patientsD Podzamczer, E Ferrer, A García, et al.
HIV Clinical Trials|October 24, 2001
Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapyM Núñez, P Saballs, M E Valencia, et al.
Journal of Neurovirology|December 28, 2017
CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON studyT J Barber, A Imaz, M Boffito, et al.
Journal of Neurovirology|January 11, 2018
Correction to: CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON studyT J Barber, A Imaz, M Boffito, et al.
Pageof 11